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Background
Pulmonary arterial hypertension (PAH) remains a dis-
ease with high morbidity/mortality in pediatrics. Under-
standing ventricular-arterial coupling, a measure of how
well matched the ventricular and vascular function is,
may elucidate the pathway leading to right heart failure.
Methods
This retrospective study included subjects with PAH
who a cardiac magnetic resonance (CMR) study within
14 days of cardiac catheterization between January
2009-August 2013. The effective elastance (Ea, index of
arterial load) and right ventricular maximal end-systolic
elastance (Emax, index of contractility) were determined
by a combination of CMR and hemodynamic data. Ea is
defined as (mean pulmonary arterial pressure minus
pulmonary capillary wedge pressure)/stroke volume.
Emax is defined as mean pulmonary arterial pressure/
end systolic volume. Ea/Emax ratio was derived. Addi-
tionally, a measure of non-invasive ventricular arterial
coupling (assuming PWCP is insignificant, making Ea/
Emax = end systolic volume/stroke volume) was derived
from only CMR. Pulmonary vascular resistance indexed
(PVRi) and pulmonary vascular reactivity, as defined by
Barst criteria (decrease in mean pulmonary artery pres-
sure of > 20%, unchanged/increased cardiac index, and
decreased/unchanged pulmonary to systemic vascular
resistance ratio), were also determined. Pearson correla-
tion coefficients were calculated between PVRi and Ea,
Emax, and Ea/Emax. Receiving operating characteristic
(ROC) curve analysis determined the diagnostic value of
Ea/Emax in predicting vascular reactivity.
Results
Sixteen subjects were identified for inclusion with equal
gender distributions. Age ranged from 3 months to 23
years (mean 11.3+7.4 years). Ea and Ea/Emax increased
with increasing severity defined by PVRi, with p < 0.001
for both. Ea/Emax (range 0.43-2.82) was highly correlated
with PVRi (r = 0.92, 95% CI 0.79-0.97, p < 0.0001). Non-
invasively derived ventricular arterial coupling was found
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Figure 1 Regression of ventricular arterial coupling ratio
(Ea/Emax) and pulmonary vascular resistance indexed by
reactivity. The shaded areas represent the 95% confidence interval
for each regression line. The lines depict different trajectories based
on reactivity, which approached, but not reach statistical
significance (p > 0.05).
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to be significantly correlated with PVRi (r = 0.85, 95% CI
0.62-0.95, p < 0.0001), but with a lower correlation coeffi-
cient than with Ea/Emax derived from combined hemody-
namic and CMR data. Regression of Ea/Emax and PVRi
demonstrated differing lines when separated by reactivity,
however, the lines were not significantly different (Figure
1). ROC curve analysis (Figure 2) revealed high accuracy
of the Ea/Emax ratio in determining vascular reactivity.
Ea/Emax of 0.85 had a sensitivity of 100% and a specificity
of 80%. The area under the curve is 0.89 (p = 0.008), sug-
gesting good discrimination between those who were and
were not reactive.
Conclusions
Measurement of ventricular arterial coupling, Ea/Emax,
in pediatrics is feasible. Pulmonary vascular non-reactiv-
ity may be due to ventricular-arterial decoupling in
which ventricular contractility fails to parallel increasing
afterload in severe PAH. Use of Ea/Emax may have sig-
nificant prognostic implication.
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Figure 2 Receiver operating characteristic curve demonstrating
an optimal threshold Ea/Emax ratio of 0.85. Using this criterion,
is associated with a sensitivity of 100% and a specificity of 80%.
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